Xstrahl to Highlight Orthovoltage Radiotherapy in Veterinary Oncology at ESVONC 2024
Visit the Xstrahl Stand to Meet Dr. Olivier Keravel of Eiffelvet, France
![](https://xstrahl.b-cdn.net/wp-content/uploads/2024/05/dog-rt-e1684942160176-1-500x317.jpg)
Xstrahl 300 at Eiffelvet in France
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will highlight orthovoltage radiation therapy used in veterinary oncology at the ESVONC 2024 conference to be held at The Grand Hotel Bucharest from May 23-25 in Bucharest, Romania.
Specialty veterinary practices around the world have been using radiation as an important modality to treat cancer and reduce inflammation in animals. Low energy, X-ray radiotherapy is an important and cost-effective treatment for skin cancer, dermatological disorders, certain types of benign diseases, and some palliative care in small and exotic companion animals.
Xstrahl is pleased to be attending the ESVONC 2024 conference in Bucharest. We welcome Dr. Olivier Keravel from Eiffelvet in France to the Xstrahl stand. Dr. Keravel is an expert in using our Xstrahl 300 system in his veterinary practice to treat many conditions. He will be available to speak about the workflow in his practice and answer questions about using orthovoltage radiation therapy.
Meet us at ESVONC to find out how you can implement cost-effective radiation treatment in your practice quickly and easily. To learn more about orthovoltage radiation therapy in veterinary oncology, visit https://xstrahl.com/esvonc-2024/
To schedule a time to meet Dr. Olivier Keravel or learn more about orthovoltage radiation therapy, please email asadkhan@xstrahl.com
Visit the Xstrahl stand at ESVONC from May 23-25, 2024, in Bucharest, Romania.
# # #
About Xstrahl
Xstrahl is a medical technology company that designs radiation delivery devices to support clinical teams and cancer researchers. For more than 25 years, Xstrahl has been shaping the development of superficial and orthovoltage radiation therapy and advancing preclinical radiation research. Xstrahl systems are in operation at more than 700 treatment and research facilities worldwide.
To learn more about Xstrahl at ESVONC 2024, visit www.com/xstrahl.com/esvonc-2024/
To learn more about all Xstrahl clinical and research systems, visit www.xstrahl.com